Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Spine|December 20, 2012
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspectiveRonald Wielage, Megha Bansal, Kinsley Wilson, et al.
Urology Annals|February 7, 2015
Diffuse large B-cell non-Hodgkin lymphoma of the prostate presenting with urinary outlet obstruction: A case reportRam Nawal Rao, Megha Bansal, Shiwanjali Raghuvanshi, et al.
Applied Health Economics and Health Policy|June 25, 2018
Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled DiabetesMegha Bansal, Mona Shah, Brian Reilly, et al.
Applied Health Economics and Health Policy|April 26, 2013
Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspectiveRonald C Wielage, Megha Bansal, J Scott Andrews, et al.
Reviews on Recent Clinical Trials|December 17, 2013
Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical TrialsAlbert Farrugia, Megha Bansal, Sonia Balboni, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 18, 2018
Identification of a splice variant of optineurin which is defective in autophagy and phosphorylationShivranjani C Moharir, Megha Bansal, Gopalakrishna Ramachandran, et al.
Arthritis Care & Research|May 31, 2014
Cost effectiveness of duloxetine for osteoarthritis: a Quebec societal perspectiveRonald C Wielage, Ankur J Patel, Megha Bansal, et al.
Toxicology and Applied Pharmacology|August 24, 2018
COX-2/EP2-EP4/β-catenin signaling regulates patulin-induced intestinal cell proliferation and inflammationNeha Singh, Megha Bansal, Saurabh Pal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2013
The cost-effectiveness of duloxetine in chronic low back pain: a US private payer perspectiveRonald C Wielage, Megha Bansal, J Scott Andrews, et al.
Toxicology|December 4, 2018
Alternariol induced proliferation in primary mouse keratinocytes and inflammation in mouse skin is regulated via PGE<sub>2</sub>/EP2/cAMP/p-CREB signaling pathwayMegha Bansal, Neha Singh, Shamshad Alam, et al.
Pageof 3